Web Stats Provided By Google Analytics

Thursday, November 30, 2017

CymaBay Therapeutics (CBAY) Rating Reiterated by HC Wainwright

... company's stock valued at $5,712,000 after acquiring an additional 170,126 shares in the last quarter. Finally, Ardsley Advisory Partners raised its position in shares of CymaBay Therapeutics by 66.2% during the 2nd quarter. Ardsley Advisory ...
http://ift.tt/2AgOdqL

No comments:

Post a Comment

Popular Ardsley Roundup Posts